WO2008097970A2 - Compositions immunogènes de grippe canine et procédés d'utilisation de celles-ci - Google Patents

Compositions immunogènes de grippe canine et procédés d'utilisation de celles-ci Download PDF

Info

Publication number
WO2008097970A2
WO2008097970A2 PCT/US2008/053050 US2008053050W WO2008097970A2 WO 2008097970 A2 WO2008097970 A2 WO 2008097970A2 US 2008053050 W US2008053050 W US 2008053050W WO 2008097970 A2 WO2008097970 A2 WO 2008097970A2
Authority
WO
WIPO (PCT)
Prior art keywords
canine
administered
equine
antigen
flu antigen
Prior art date
Application number
PCT/US2008/053050
Other languages
English (en)
Other versions
WO2008097970A3 (fr
Inventor
John Randall Swart
Original Assignee
Boehringer Ingelheim Vetmedica, Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Ingelheim Vetmedica, Inc. filed Critical Boehringer Ingelheim Vetmedica, Inc.
Publication of WO2008097970A2 publication Critical patent/WO2008097970A2/fr
Publication of WO2008097970A3 publication Critical patent/WO2008097970A3/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/145—Orthomyxoviridae, e.g. influenza virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5252—Virus inactivated (killed)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A61K2039/552—Veterinary vaccine
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/16011—Orthomyxoviridae
    • C12N2760/16111—Influenzavirus A, i.e. influenza A virus
    • C12N2760/16134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein

Abstract

La présente invention concerne des compositions et des procédés apparentés à la grippe canine. En particulier, la présente invention propose des compositions efficaces pour la réduction de l'incidence de, la réduction de la sévérité de, ou la prévention d'une infection par la grippe canine. Des procédés d'administration de telles compositions sont également proposés. Dans des modes de réalisation préférés, les compositions de la présente invention comprennent des antigènes dérivés de souches de la grippe H3N8.
PCT/US2008/053050 2007-02-05 2008-02-05 Compositions immunogènes de grippe canine et procédés d'utilisation de celles-ci WO2008097970A2 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US88821307P 2007-02-05 2007-02-05
US60/888,213 2007-02-05

Publications (2)

Publication Number Publication Date
WO2008097970A2 true WO2008097970A2 (fr) 2008-08-14
WO2008097970A3 WO2008097970A3 (fr) 2008-12-11

Family

ID=39682380

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2008/053050 WO2008097970A2 (fr) 2007-02-05 2008-02-05 Compositions immunogènes de grippe canine et procédés d'utilisation de celles-ci

Country Status (1)

Country Link
WO (1) WO2008097970A2 (fr)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10555998B2 (en) 2014-11-24 2020-02-11 Intervet Inc. Inactivated equine influenza virus vaccines

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
DALY ET AL.: 'Current perspectives on control of equine influenza' VETERINARY RESEARCH vol. 35, 2004, pages 411 - 423 *
DALY: 'Equine influenza in dogs: Too late to bolt the stable door' THE VETERINARY JOURNAL vol. 171, 2006, pages 7 - 8 *

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10555998B2 (en) 2014-11-24 2020-02-11 Intervet Inc. Inactivated equine influenza virus vaccines

Also Published As

Publication number Publication date
WO2008097970A3 (fr) 2008-12-11

Similar Documents

Publication Publication Date Title
JP6395855B2 (ja) ブタ流行性下痢ウイルスワクチン
US10799578B2 (en) Vaccine against porcine parvovirus
US20200237894A1 (en) Pcv2 orf2 carrier platform
US9636389B2 (en) Effective method of treatment of porcine circovirus and Lawsonia intracellularis infections
US20220313812A1 (en) Senecavirus a immunogenic compositions and methods thereof
KR20120042865A (ko) 가금류의 예방접종 방법 및 조성물
EA035265B1 (ru) Вариант белка opc2 pcv2 и содержащие его вирусоподобные частицы
JP2022538673A (ja) アフリカ豚熱ワクチン
US20140348874A1 (en) Method for the reduction of pcv-2 in a herd of swine
US11896659B2 (en) Porcine Circovirus Type 3 (PCV3) vaccines, and production and uses thereof
US20140328877A1 (en) West nile virus vaccine
US20150202282A1 (en) Pcv2 orf2 virus like particle with foreign amino acid insertion
CN115322972B (zh) 一株h9亚型禽流感病毒分离株及其应用
JP2023520803A (ja) 口蹄疫ウイルス様粒子抗原、及びそのワクチン組成物、調製方法と使用
CN110559433B (zh) 一种禽流感病毒样颗粒疫苗、及其制备方法和应用
JP2007528900A (ja) 伝染性ファブリキウス嚢症ウイルスの抗原性分離株およびワクチン
WO2008097970A2 (fr) Compositions immunogènes de grippe canine et procédés d'utilisation de celles-ci
CN114746113A (zh) 针对副鸡禽杆菌和禽脑脊髓炎病毒和禽痘病毒的三联疫苗
WO2022246449A1 (fr) Vaccins à sous-unité de protéine de spicule de sars-coronavirus 2 (sars-cov-2)

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 08729047

Country of ref document: EP

Kind code of ref document: A2

NENP Non-entry into the national phase in:

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 08729047

Country of ref document: EP

Kind code of ref document: A2